Abadan, Romel G.

HRN: 20-83-70  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
CEFTRIAXONE 1G (VIAL)
01/03/2024
01/10/2024
IV
900mg
OD
PCAP-C
Checking Final Appropriateness 
01/03/2024
OXACILLIN 500MG (VIAL)
01/03/2024
01/10/2024
IV
250mg
Q6hours
Cellulitis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: